Font Size: a A A
Keyword [evolocumab]
Result: 1 - 20 | Page: 1 of 2
1. Efficacy And Safety Of Evolocumab For Lowering LDL Cholesterol:A Meta-Analysis
2. Efficacy And Safty Of Evolocumab In Treatment Of Dyslipidemia: A Meta-Analysis
3. Meta-analysis Of The Effect Of Statins Combined With PCSK9 Inhibitor Evolocumab On Lipid Metabolism
4. The Role And Mechanism Of PCSK9 In Graft Vascular Disease
5. Efficacy And Safety Of Evolocumab In Patients With Type 2 Diabetes And Dyslipidaemia: A Meta-analysis
6. Effects Of Pro-protein Convertase Subtilisin/kexin 9 On Intestinal Tumor In ApcMin/+ Mice
7. The Short-term Lipid-lowering Efficacy And Safety Analysis Of PCSK9 Inhibitor Evolocumab In Extremely High-risk Patients With Acute Coronary Syndrome
8. The Effect Of Evolocumab On Lipid Levels,Glucose And Liver And Kidney Functions In Patients With Very High-risk ACS
9. Efficacy And Safety Of Evolocumab In Patients With Coronary Heart Disease Complicated With Dyslipidemia Security
10. Study On The Lipid-lowering Effect Of Evolocumab In Patients With Acute Coronary Syndrome
11. Analysis Of The Value Of Elojumab In Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
12. Study Of Evolocumab On Blood Lipid Level,Clinical Efficacy And Drug Safety In Patients With Coronary Multi-vessel Lesions
13. To Observe The Effect Of Evolocumab On Preventing Atherosclerotic Plaque Formation In Aop E Mice And Evaluate The Effect Of Lowing Blood Lipid
14. Cost-effectiveness Of Evolocumab Therapy In Patients With Atherosclerotic Cardiovascular Disease
15. Evaluation Of Efficacy And Safety Of Elouximab In Clinical Application
16. Effect Of PCSK9 Inhibitor Evolocumab On The Degree Of Coronary Artery Stenosis In Patients With Coronary Heart Disease
17. Evolocumab Of The Efficacy And Safety Of Ilozumab In The Treatment Of Patients With Single-Vessel Coronary Artery Disease
18. The Observation Of The Early Efficacy Of PCSK9 Inhibitors-Evolocumab In Ultra-high-risk ACS Patients
19. Clinical Application Study Of Evolocumab In Patients With ACS
20. The Clinical Study Of Evolocumab In Improving Lipid Metabolism And Carotid Atherosclerosis In ACS Patients With PCI
  <<First  <Prev  Next>  Last>>  Jump to